Publications

Recent articles and papers featuring contributions from our scientists.





Publications
14 May 2026
Sleep and circadian Technologies in Mental Health: Translating Evidence into Mental Health Solutions

Sleep and circadian Technologies in Mental Health: Translating Evidence into Mental Health Solutions





Read more
Publications
17 April 2026
End-to-end in vitro and in vivo evaluation of radiopharmaceuticals in patient-derived models


Read more
Publications
09 April 2026
Biomarker Profiling of Radiation and DDR Inhibitor Combinations in LNCaP Xenografts


Read more
Publications
25 February 2026
A human iPSC platform for studying pathogenic protein aggregation in neurodegeneration


Read more
Publications
25 February 2026
Development of CNS model for neurodegenerative drug discovery using 3D printed human iPSC-derived cells


Read more
Publications
25 February 2026
Development of a human reactive astrocyte platform for drug discovery


Read more
Publications
25 February 2026
Use of Innovative Multi-Omics Platforms to Study Neurodegenerative Disease 


Read more
Publications
20 October 2025
R&D Consulting at Medicines Discovery Catapult


Read more
Publications
20 October 2025
Application of Spatial Biology in the Evaluation of a Photodynamic Therapeutic Candidate in Melanoma Treatment 


Read more
Publications
27 June 2025
MDC Chemical Protein Stability Assay (CPSA) a novel target engagement approach


Read more





Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult